Daesang Corporation revealed it backed out from its plan to buy the China-based food company, Heilongjiang Chengfu Food Group Co. It aimed to acquire a 51% stake in the company, which has now been withdrawn.
According to The Korea Economic Daily, the original plan was to purchase over half of the company's stake, trimmed to 20%. The South Korean food giant reportedly changed its decision as the amino acid product market slowed.
Purpose of the Initial Bid
Daesang Corp. was trying to acquire a controlling stake in Heilongjiang Chengfu Food to increase its presence in the Chinese market. The latter is a leading food additives manufacturer in China, and its position would also benefit Daesang.
Daesang and Heilongjiang Chengfu Food already agreed to an up to 51% acquisition deal in 2021, worth KRW26.5 billion. However, the former announced on Thursday this week that it will just buy 20% of Chengfu Food for KRW8.84 billion. The company said the acquisition may be completed by Sept. 7
"We had to make changes to our deal given the sluggishness of the lysine business in China. Through our minority stake investment, however, we will continue cooperating with Chengfu Food in functional amino acid products such as L-arginine for feed and L-tryptophan," a Daesang official said.
Sluggish Market Pushed Daesang to Retract Bid
Finally, Daesang Group stressed that the slow market for lysine has prompted it to retract its bid. As per the Financial Supervisory Service's Electronic Disclosure System, the company revised its plan for the deal and has now reduced the stake it would buy. New Daily reported that the expected share will also be reduced from 32.87% to 20%.
Photo by: Daesang Website


Pelosi Discloses Major Intel and Uber Call Option Purchases Worth Up to $6 Million
Alphabet Replaces Verizon in Dow Jones Industrial Average
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe
Heineken Names JDE Peet’s CEO Rafael Oliveira as New Chief Executive
Fortescue Faces Class Action Over Sexual Harassment Claims at Australian Mining Sites
Bayer Wins Major U.S. Supreme Court Roundup Lawsuit, Shares Surge
Nomura Stock Upgraded to Buy by BofA as Stronger ROE and Earnings Growth Boost Outlook
Trip.com Shares Tumble After Q1 Profit Drops and Weak Revenue Growth Outlook
SK Hynix Targets $29.4 Billion Nasdaq Listing to Expand AI Chip Business
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom
Meta Reportedly Developing ‘Arena’ Prediction Market App to Rival Polymarket and Kalshi
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock
Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence
Micron Stock Surges on Strong AI Demand, Record Revenue, and Bullish Q4 Forecast
Kioxia Targets U.S. Listing as AI Chip Boom Accelerates 



